Back

ITGA11-targeted CAR macrophages attenuate cardiac fibrosis and improve functional recovery post-myocardial infarction

31 August 2026 (15:00 - 15:10)
Organised by: Logo
Congress Presentation Part of: Therapeutic targeting and cardiac repair strategies Fibrosis ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Yang Xu

Zhongda Hospital, Southeast University, Nanjing (China)

4 More presentations in this session

Presentation thumbnail
Therapeutic targeting of ADAM8 with isoacteoside mitigates myocardial infarction injury via OPA1-mediated mitochondrial fusion dynamics
Doctor W. Luo (CN)
Abstract
Presentation thumbnail
Mitochondria-derived peptide hydrogel enhances mitochondrial transplantation and promotes cardiac repair through macrophage metabolic reprogramming
Ms H. Li (Beijing, CN)
Abstract
Presentation thumbnail
Ultrasound-mediated spatiotemporally controlled delivery of miRNAs regulates apoptosis and maturation of hiPSC-CMs at the organelle level to enhance the therapeutic effect of myocardial infarction
Professor Y. Mu (Urumqi, CN)
Abstract
Presentation thumbnail
Spatiotemporal dissection and ultrasound-targeted modulation of the COL6A1–LAMININ signalling axis in post-myocardial infarction border zone fibrosis
Doctor L. Qian (Nanjing, CN)
Abstract

Access the full session

Session thumbnail
Therapeutic targeting and cardiac repair strategies

The Event

Event poster

ESC Congress 2026

31 August 2026 15:00 CET
You may be interested in
thumbnail
Congress Presentation
Activation of cardiac macrophages, endothelial cells and fibroblasts in experimental autoimmune myocarditis
29 August 2022
thumbnail
Congress Presentation
Evaluation of alphavbeta3 integrin-targeted positron emission tomography and photoacoustic tracer for imaging of carotid plaque in apoE-/- mice
1 September 2019
thumbnail
Congress Presentation
Cardiovascular complications of chimeric antigen receptor (CAR)-t cell therapy: insights from a regional cardio-oncology program
21 June 2025
thumbnail
Congress Presentation
Inhibition of fractalkine signalling reduces intramyocardial haemorrhage and left ventricular thrombus in patients with acute myocardial infarction by modulating immunothrombosis (The FRACTAL trial)
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources